FIELD: medicine.
SUBSTANCE: invention refers to a deuterium-enriched α-ketoamide compound of formula wherein: D means a deuterium atom; the values R1-R5 are presented in cl.1 of the patent claim, and to a based pharmaceutical composition.
EFFECT: method improvement.
32 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
SERINE PROTEASE INHIBITORS | 2006 |
|
RU2441020C2 |
METHODS AND INTERMEDIATE COMPOUNDS FOR PRODUCING STERIC COMPOUNDS | 2007 |
|
RU2481326C2 |
METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
THIAZOLIDINEDIONE ANALOGUES | 2007 |
|
RU2445957C2 |
N-HYDROXYLSULPHONAMIDE DERIVATIVES AS NOVEL PHYSIOLOGICALLY USEFUL NITROXYL DONORS | 2008 |
|
RU2485097C2 |
Authors
Dates
2012-10-27—Published
2007-03-14—Filed